Epidemiology

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

Kleincellige en niet-kleincellige longkanker: diagnose, behandeling en opvolgingPublished by: KCELast published: 2013Cancer du poumon à petites cellules et non à petites cellules : diagnostic, traitement et suiviPublished by: KCELast published: 2013

Lung cancer is the leading cause of cancer mortality in the US in both men and women, and the leading cause of cancer-related deaths worldwide.[12][13]

In the US, in 2025, it is estimated that there will be 226,650 new cases of lung cancer and 124,730 deaths from lung cancer.[12] Globally, lung cancer accounted for 1.8 million deaths in 2020.[14]

Age-adjusted lung cancer incidence in the US (2018-2022) is higher in males than in females (53.1 new cases per 100,000 vs. 43.9 cases per 100,000, respectively).[15] Median age at diagnosis in the US is 71 years.[15] Incidence rates are highest in non-Hispanic black males.[15]

Globally, smoking is the leading cause of lung cancer, accounting for 85% of all cases.[13] Recent declines in the incidence rate of lung cancer (approximately 2% decrease per year since the mid-2000s in the US and 6.5% decrease in age-standardised incidence globally between 2010 and 2019) may relate to reductions in tobacco use in more recent decades.[16][17]​​​​ However, in 2022, an estimated 11.6% of the US population (28.8 million) still smoked tobacco.[18]

Use of this content is subject to our disclaimer